肾癌：CCR4：肾细胞癌的新靶点。 - Suppr

Suppr

超能文献

Kidney cancer: CCR4: a new target for RCC.

作者信息

Allison Susan J

出版信息

Nat Rev Nephrol. 2017 Apr;13(4):192. doi: 10.1038/nrneph.2017.14. Epub 2017 Feb 13.

DOI:10.1038/nrneph.2017.14

PMID:28190878

Abstract

摘要

相似文献

Kidney cancer: CCR4: a new target for RCC.肾癌：CCR4：肾细胞癌的新靶点。

Nat Rev Nephrol. 2017 Apr;13(4):192. doi: 10.1038/nrneph.2017.14. Epub 2017 Feb 13.

Renal cell carcinoma and mimics: pathologic primer for radiologists.肾细胞癌及类似病变：放射科医生病理入门。

AJR Am J Roentgenol. 2012 Jun;198(6):1289-93. doi: 10.2214/AJR.12.8586.

Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.肾细胞癌/肾祖细胞嵌合体类器官作为一种新的肿瘤发生基因发现模型。

Dis Model Mech. 2017 Dec 19;10(12):1503-1515. doi: 10.1242/dmm.028332.

Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.1型和2型肝细胞生长因子激活剂抑制剂由肾脏中的肾小管上皮表达，并在肾细胞癌中下调。

J Urol. 2004 Feb;171(2 Pt 1):890-6. doi: 10.1097/01.ju.0000092861.21122.d2.

Routine ultrasonography surveillance of native kidneys for renal cell carcinoma in kidney transplant candidates.对肾移植候选者的天然肾脏进行肾细胞癌的常规超声检查监测。

Clin Transplant. 2016 Aug;30(8):946-53. doi: 10.1111/ctr.12769. Epub 2016 Jul 25.

Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma.COX - 2在正常肾、肾盂肾炎肾、肾上皮内瘤变及肾细胞癌中的表达。

Eur Urol. 2006 Jul;50(1):92-7; discussion 97. doi: 10.1016/j.eururo.2005.12.039. Epub 2006 Jan 6.

Kidney cancer: Targeting metabolism in RCC.

Nat Rev Nephrol. 2017 Jun;13(6):320. doi: 10.1038/nrneph.2017.57. Epub 2017 Apr 19.

Differences in Clinical and Pathological Features of Renal Cell Carcinoma Between Japanese Patients After Kidney Transplantation and Those on Hemodialysis.肾移植后日本患者与接受血液透析的日本患者肾细胞癌临床和病理特征的差异。

Ther Apher Dial. 2017 Apr;21(2):133-138. doi: 10.1111/1744-9987.12509. Epub 2017 Feb 10.

CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53.CNPY2促进肾癌细胞增殖并增加TP53的表达。

Biochem Biophys Res Commun. 2017 Apr 1;485(2):267-271. doi: 10.1016/j.bbrc.2017.02.095. Epub 2017 Feb 21.

Kidney cancer: S1P--a promising target in sunitinib-resistant RCC.肾癌：鞘氨醇-1-磷酸——在对舒尼替尼耐药的肾细胞癌中一个有前景的靶点。

Nat Rev Urol. 2015 Mar;12(3):123. doi: 10.1038/nrurol.2015.16. Epub 2015 Feb 3.

引用本文的文献

Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesis.非甾体抗炎药（阿司匹林和萘普生）对 TMPRSS2-ERG（融合）驱动的前列腺癌发生过程中，小鼠血浆和前列腺中炎症相关蛋白质组学谱的影响。

Mol Carcinog. 2024 Jun;63(6):1188-1204. doi: 10.1002/mc.23718. Epub 2024 Mar 20.

Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy Cancer Patients.健康供者和不同放疗癌症患者中的转录炎症特征。

Int J Mol Sci. 2024 Jan 16;25(2):1080. doi: 10.3390/ijms25021080.

PET Imaging Radiotracers of Chemokine Receptors.趋化因子受体的正电子发射断层扫描（PET）成像放射性示踪剂

Molecules. 2021 Aug 26;26(17):5174. doi: 10.3390/molecules26175174.

Dual Repressive Function by Cip1, a Budding Yeast Analog of p21, in Cell-Cycle START Regulation.Cip1（一种芽殖酵母中与p21类似的蛋白）在细胞周期起始调控中的双重抑制功能。

Front Microbiol. 2020 Jul 9;11:1623. doi: 10.3389/fmicb.2020.01623. eCollection 2020.

Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions.癌症微环境中的通讯作为治疗干预的靶点

Cancers (Basel). 2020 May 14;12(5):1232. doi: 10.3390/cancers12051232.

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.趋化因子及其受体：癌症免疫治疗的新靶点。

Front Immunol. 2019 Mar 6;10:379. doi: 10.3389/fimmu.2019.00379. eCollection 2019.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验